Skip to content
FDAMedicinesClass IIOngoing

FDA recall 98034: Breckenridge Pharmaceutical, Inc.: Duloxetine Delayed-Release Capsules and 1 more

FDA recall 98034 ·

Build snapshot. Collected , once, when this site was built. It is not a live feed.

Check my lot or code

Is yours in this recall?

Type the lot, batch, date code, model number or UPC printed on the product. It is compared here, in your browser, with the codes this notice lists. It stays in this page: it is not added to the address.

General information on recalls from the agency: U.S. Food and Drug Administration (opens in a new tab).

What the agency says to do

FDA’s record gives no instruction for consumers.

Status: Ongoing. What the FDA’s recall statuses mean (opens in a new tab)

Note from Recalls Watch, not agency text

Why it was recalled

CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
Text from FDA, unedited.

FDA classification: Class II. What the FDA’s classes mean (opens in a new tab)

The recalled product

Codes in the record. Click one to copy it.

  • Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Manufactured for : Quallient Pharmaceuticals Health, LLC, Grand Cayman, Cayman Islands, NDC 82009-032-10.

    Lot or code
    Lot #: 240947C, 240962C, Exp. Date 04/2027
    FDA recall number
    D-0215-2026
    Quantity
    3397 bottles
  • Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceutical Inc., Berkeley Heights, NJ 07922 NDC 51991-748-10.

    Lot or code
    Lot #: 240534C, Exp. Date 01/2027; 240977C, Exp. Date 04/2027.
    FDA recall number
    D-0216-2026
    Quantity
    7389 bottles

Distribution (FDA): Nationwide within the United States

Source

Issued by
U.S. Food and Drug Administration
Firm
Breckenridge Pharmaceutical, Inc.
Title
Composed by Recalls Watch from fields of the record; FDA records have no title.

Check all notices that name this firm in the directory of recalls by brand and manufacturer. This notice is in these lists: Firm: Breckenridge Pharmaceutical, Inc., Medicine: Duloxetine, Month: December 2025, Week 2025-W50. Browse more medicines recalls, or check another notice by its number in the recall number lookup.

About this recall

What is the hazard?

FDA states: “CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit”

What should I do if I have this product?

FDA’s record gives no instruction for consumers. The official report is linked on this page.

How do I know if my product is included?

Compare the lot or code printed on your product with the codes FDA lists on this notice, product by product.

How does the code check on this page work?

You type the lot, batch, date code, model number or UPC from your package and the page compares it, in your browser, with the codes FDA lists on this notice. It reports a match, a possible match (your code is part of a longer listed code) or no match. It only compares text: a notice that describes products by dates, sizes or “all lots” cannot be compared, so “no match” does not clear a product. The comparison runs in your browser and the page does not send the code anywhere, and the code stays out of the page address. Only if you press “Copy link to this result” is a link made that carries it, and whoever opens that link requests that address from this site.

When was this recall published?

FDA published recall 98034 on December 10, 2025.

Other notices of Breckenridge Pharmaceutical, Inc.